Towards Healthcare
Drug Repurposing Market to Surge USD 2506.64 Mn by 2035

Drug Repurposing Market Fueled by Emerging Biologics Demand

Based on market forecasts, the global drug repurposing market, projected at USD 636.95 million in 2025, is expected to reach USD 2506.64 million by 2035, growing at a CAGR of 14.76% over the forecast period. The world is demanding faster, more affordable alternatives for the traditional drug development process. North America registered dominance with a supportive regulatory framework.

Content

  • Last Updated: 06 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The drug repurposing market holds a valuation of USD 730.96 million as of 2026, and will expand to USD 2506.64 billion by 2035, achieving a CAGR of 14.76% between 2026 and 2035.

North America is currently leading the drug repurposing market due to the presence of advanced research infrastructure and supportive regulatory guidelines.

The drug repurposing market includes four segments such as by type of approach, by therapeutic area, by drug molecules, and by region.

Key trends include the increasing demand for cost-effective drug development, growth in small molecules, and innovations in AI and other technologies.

The market comprises concerns regarding intellectual property, regulatory pathway, profitability, and needed testing.

US FDA, NIH, NCATS, MHRA, ClinicalTRials.gov, EMA, CDSCO.
Any Questions